How to Spot a Pre-IPO Share Markup Scheme Before You Wire Money

TL;DR: The SEC's August 2026 complaint against Andrew Spaventa and his three entities (The Spaventa Group LLC, TSG Capital Advisors LLC, and TSG Alpha Partners LLC) describes a $74 million boiler-room operation that sold pre-IPO shares in SpaceX, Anthropic, Anduril, and Perplexity to 800+ investors, including 100+ retirees, while charging undisclosed markups averaging 46% and peaking at 91% above Spaventa's actual acquisition cost. Investors were told fees were 0% or capped at 12.5%. Read the SEC's official press release and understand that this case is still unfolding. If you are an accredited investor being pitched any pre-IPO deal right now, the checklist below will help you tell the difference between a legitimate SPV and a scheme designed to extract your capital invisibly.

How the Spaventa Scheme Actually Worked

I've seen pitch decks for pre-IPO funds for years. The best ones are boring. They list the company, the share class, the price paid, the carry structure, and the risks in plain language. The Spaventa pitch was the opposite of boring, and that contrast is worth studying in detail.

Between December 2020 and June 2025, Spaventa raised more than $74 million across 11 private funds by cold-calling and email-blasting retail investors. The target companies had genuine brand recognition: SpaceX, Anthropic, Anduril, Perplexity, and Kraken. That name recognition is not incidental to the scheme. It is the scheme. Investors associate those names with transformative returns, which reduces their skepticism and speeds up their decision to wire money.

The mechanics involved three layers. First, Spaventa or entities he controlled acquired pre-IPO shares on the secondary market at a known price. Second, those shares were transferred into SPVs, which are single-purpose LLCs created to hold one investment. Third, investor capital was used to buy into the SPV at a price that was 27% to 91% higher than the acquisition cost, with more than $23 million in total captured as undisclosed profit before any investor could track it.

A critical piece of the mechanical setup was backdated subscription agreements and side letters. According to the SEC's litigation release in case no. 26-civ-06958 (S.D.N.Y.), documents were created or altered to obscure when and at what price Spaventa had actually acquired the shares. This made independent price verification nearly impossible for investors doing standard due diligence.

The sales force numbered more than 100 agents who worked on commission. Spaventa personally received approximately $4 million, reportedly spent on luxury cars and home renovations. The agents collectively received more than $12 million. The investors were told commissions were 0% or at most 12.5%. None of those disclosures reflected the true economics because the real profit mechanism was the per-share markup, not a line-itemed commission.

The SEC's case description, covered by Fortune on August 15, 2026, notes that as of the complaint date, the vast majority of investors had not recouped their capital. Some suffered total or near-total losses. This is not a story about investors who got modest underperformance. Many of them may lose everything they put in.

The Pre-IPO Due-Diligence Checklist

This checklist is designed for accredited investors, meaning people who meet the SEC's income or net-worth thresholds and therefore get access to private offerings that are not available to the general public. That access is a privilege, but it comes with reduced regulatory protection compared to public markets. You are expected to conduct your own due diligence. Here is how to do it.

Verify Registration Before the First Substantive Conversation

• Go to FINRA BrokerCheck and search every individual who contacts you. A registered broker-dealer representative will appear there with their CRD number, employment history, and any disclosed disciplinary actions. If they do not appear, or if they appear with a suspension or bar, stop the conversation.
• If the person or firm claims to be a registered investment adviser (RIA) rather than a broker-dealer, verify them through the SEC's Investment Adviser Public Disclosure database (IAPD). RIAs managing over $100 million register with the SEC. Smaller firms register with their state regulator.
• Ask directly: "Are you registered as a broker-dealer or RIA? What is your CRD number?" A legitimate professional will answer immediately. Hesitation or deflection is disqualifying.
• The Securities Exchange Act of 1934 requires anyone receiving transaction-based compensation for securities sales to be a registered broker-dealer. "Referral fee," "finder's fee," and "placement fee" are common euphemisms for unregistered broker-dealer activity. If those phrases come up, ask for the person's FINRA registration number.

Demand the Acquisition Cost Basis in Writing

• Before you sign anything, ask: "What did the fund or SPV pay per share to acquire these shares on the secondary market, and on what date?" Get the answer in writing, not verbally on a call.
• Request the actual purchase agreement or transfer confirmation showing the price paid. Legitimate sponsors can produce this. The Spaventa operation backdated or obscured these documents. If a sponsor says the cost basis is confidential or proprietary, that is a red flag severe enough to walk away on its own.
• Compare the cost basis to the price you are being charged. A markup for legal, administrative, and carry costs is normal in a legitimate fund. A 46% markup to cover undisclosed profit is not. Ask for a line-by-line breakdown of how the offering price was derived from the acquisition cost.
• Ask whether the fund or SPV is transacting on a principal basis (meaning it already owns the shares and is reselling them to you) or an agency basis (meaning it is buying on your behalf). Principal transactions create markup risk. Agency transactions require disclosure of the transaction price. Know which structure you are in.

Identify Every Layer of SPV Stacking

• Ask: "Is this fund investing directly in shares, or is it investing into another fund or SPV that holds the shares?" Each added layer is another potential markup point and another layer of opacity.
• Request the full fund structure in a written diagram or description. You need to know who holds the shares at the bottom of the stack, what entity you are investing into, and what entities sit between those two.
• Confirm that the shares at the bottom of the stack are actually held and not subject to pending agreements that could fall through. Pre-IPO secondary deals can fail to close. Some operators raise money before they have secured the shares.
• Review the operating agreement of the SPV you are investing into. You should have contractual rights, a defined timeline for either an IPO event or a buyout, and a clear liquidation mechanism. If the operating agreement gives the manager unchecked discretion over valuation and distributions, that language is protecting the manager, not you.

Recognize the Sales Red Flags

• "No hidden fees" claims in a pitch deck or sales call are not a legal disclosure. They are a marketing statement. The Spaventa pitch used that framing while the fee was embedded as a markup in the share price itself. Real disclosure means specifying every dollar of spread, carry, and management fee with actual numbers.
• High-pressure urgency language ("this allocation closes Friday," "we only have three spots left") is a sales tactic, not a market reality. Legitimate pre-IPO deals have real allocation constraints, but legitimate sponsors do not pressure investors into same-week decisions on five-figure or six-figure commitments.
• Cold calls or unsolicited emails about pre-IPO deals in high-profile companies should immediately raise your skepticism. The FINRA investor guidance on pre-IPO risks published August 18, 2026 specifically flags unsolicited outreach as a primary warning sign.
• Watch for name-dropping without documentation. "We source our deals through the same channels as [major VC firm]" is unverifiable. Ask for the name of the transfer agent who approved the share transfer and contact them independently.

Verify Written-Consent Requirements

• Most private company share transfer agreements require board or transfer-agent approval before secondary sales close. Ask your sponsor to show you written approval from the company's transfer agent or legal counsel confirming the transfer is authorized.
• The Securities Act of 1933 governs how private securities are sold and to whom. Confirm that the offering has a valid exemption, typically Regulation D Rule 506(b) or 506(c). Ask for the Form D filing number and look it up on SEC EDGAR to confirm it exists and matches what you were told.
• If a fund claims to have transfer approval but cannot produce written documentation, assume the claim is unverified. Some boiler-room operators raise money and then scramble to acquire shares afterward, which puts your capital at risk from day one.

Red Flags vs. What a Legitimate Deal Looks Like

Red Flag	What a Legitimate Sponsor Does
Sales agent not on FINRA BrokerCheck or SEC IAPD	Registered broker-dealer or RIA with CRD number provided on request
"No fees" or "0% commission" language with no cost-basis disclosure	Written disclosure of acquisition cost, markup, carry, and management fee before you sign
Refuses to provide purchase date and price paid for shares	Provides actual purchase confirmation or transfer agreement on request
SPV layering with no explanation of structure	Written fund structure diagram with each layer's role explained
No Form D filing on SEC EDGAR	Valid Reg D exemption with verifiable Form D filing number
Unsolicited cold call with high-pressure close deadline	Inbound relationship or warm referral with adequate time to review documents
No written transfer-agent approval from issuer	Transfer approved in writing by the company's legal team or transfer agent
"Referral fee" or "finder's fee" language for transaction-based compensation	Compensation structure clearly labeled and tied to a registered entity

What You Should Do Right Now If You Are Already Invested

If you recognize any of these patterns in a deal you have already committed to, you have options, but you need to act without delay. The New York Law Journal's coverage of the Spaventa charges notes that the SEC froze assets early in the case. Asset freezes at the SEC level often come in tandem with the complaint, meaning the window between fraud and enforcement action can be very short.

Contact an attorney who practices securities law before you do anything else. Do not contact the sponsor directly to confront them. Doing so can accelerate asset dissipation. Report what you know to the SEC's online tip portal and to FINRA's investor complaint center. If you are in New York, the SDNY has jurisdiction over the Spaventa case. Cases in other jurisdictions may involve different U.S. Attorney's offices or state securities regulators.

I want to be direct about something: even with every item on this checklist completed, pre-IPO investing carries real risk in legitimate deals. Shares that cannot be transferred until an IPO that may never come, valuations that have no public-market anchor, and lockup periods that can stretch for years are all standard features of this asset class. The checklist does not make the investment safe. It makes the fraud detectable before you wire money. Those are two different things, and you need to hold both truths at the same time.

Frequently Asked Questions

Is every pre-IPO SPV a scam?

No. Legitimate pre-IPO funds and SPVs operate in every major financial center and are used by institutional investors, family offices, and accredited individuals to access private-company growth before an IPO. The key differences are registration, disclosure, and documentation. A legitimate sponsor is registered, discloses every cost including markup, and can produce purchase confirmations. The problem is that the Spaventa case shows how closely a fraudulent operation can mimic the surface appearance of a legitimate one, which is exactly why verification through FINRA BrokerCheck and SEC EDGAR cannot be skipped.

What does "accredited investor" status actually protect me from?

Accredited investor status gives you access to private offerings that are exempt from full SEC registration, but it does not give you additional fraud protection compared to a retail investor. Private offerings are not subject to the same mandatory disclosure requirements as public securities, which is precisely the gap that the Spaventa operation and others like it have exploited. The SEC's anti-fraud rules under the Securities Act of 1933 and Securities Exchange Act of 1934 still apply to private offerings, but enforcement after the fact is cold comfort if the money is already gone.

How do I verify that the shares actually exist before I invest?

Ask the sponsor to provide the name and contact information for the company's transfer agent, the specific share certificate or unit identification number, and written confirmation from the company's legal counsel or transfer agent that the transfer has been approved. Then contact the transfer agent directly using a phone number you find independently, not one provided by the sponsor. If the sponsor cannot or will not provide transfer-agent contact information, treat that refusal as evidence that the shares may not exist in the form being represented.

What if the sponsor says a markup is standard practice?

A markup on a principal transaction is legal when it is disclosed. The word "disclosed" has a specific legal meaning here: it must be written, specific in dollar or percentage terms, and provided before you commit capital. "Standard practice" is not a disclosure. The Spaventa operation collected a 46% average markup that it never disclosed at all, then claimed fees were 0%. If a sponsor tells you markups are standard but cannot tell you the exact markup percentage and cannot show you the acquisition cost against which that percentage is calculated, you do not have the information you need to make an informed decision.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.